The Ademi Firm is investigating Paragon 28 (NYSE: FNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Zimmer Biomet. Click here to learn how to join our ...

Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of the waiting ...

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Paragon 28, Inc. (NYSE:FNA). In a filing disclosed on March 06th, the Representative disclosed that they had sold between $1,001 ...

Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation in the American Academy of ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (NYSE: FNA) to Zimmer ...

Feb. 28, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that it has ...

The site in New Albany, Ohio, is now set to be completed in 2030, with operations starting as late as 2031, compared with the original operations start date that was set for 2025.

Paragon Bank’s SME Lending division has provided building, civil engineering, construction and aviation firm TSL Contractors ...

COLUMBUS, Ohio, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.